» Articles » PMID: 14522813

American Thoracic Society/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency

Overview
Specialty Critical Care
Date 2003 Oct 3
PMID 14522813
Citations 295
Affiliations
Soon will be listed here.
Citing Articles

Clinical and Economic Outcomes in Patients With Alpha-1 Antitrypsin Deficiency in a US Medicare Advantage Population.

Khandelwal N, Hinson J, Nguyen T, Daviano A, Xu Y, Suehs B J Health Econ Outcomes Res. 2025; 12(1):66-74.

PMID: 39991078 PMC: 11846658. DOI: 10.36469/001c.127446.


Alpha-1 Antitrypsin as a Regulatory Protease Inhibitor Modulating Inflammation and Shaping the Tumor Microenvironment in Cancer.

Xiang S, Yang L, He Y, Ding F, Qiao S, Su Z Cells. 2025; 14(2).

PMID: 39851516 PMC: 11763672. DOI: 10.3390/cells14020088.


Alpha-1 antitripsyn deficiency and augmentation therapy in pregnancy: two case reports.

Annunziata A, Fiorentino G, Coppola A, Cauteruccio R, Ferrentino L, Fiorentino L Front Med (Lausanne). 2024; 11:1479877.

PMID: 39736979 PMC: 11682898. DOI: 10.3389/fmed.2024.1479877.


Clinical implications of the SERPINA1 variant, M, and alpha-1 antitrypsin deficiency in Türkiye.

Karadogan D, Dreger B, Osaba L, Ahmetoglu E, Ozyurt S, Yilmaz Kara B BMC Pulm Med. 2024; 24(1):622.

PMID: 39696116 PMC: 11657439. DOI: 10.1186/s12890-024-03421-y.


COVID-19 in Individuals with Severe Alpha 1-Antitrypsin Deficiency.

Tanash H, Tahiri Blakaj E, Piitulainen E, Zaigham S Int J Chron Obstruct Pulmon Dis. 2024; 19:2661-2669.

PMID: 39677831 PMC: 11639877. DOI: 10.2147/COPD.S482323.